The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).
Methylprednisolone acetate 20mg/mL, 40mg/mL, 80mg/mL; susp for IM, intra-articular, soft tissue, or intralesional inj; contains preservative (benzyl alcohol); single-dose vial 40mg/mL, 80mg/mL ...
The FDA is also reviewing a lower 180mg maintenance dose. Thomas Hudson, AbbVie's chief scientific officer, said Skyrizi is the first new drug to be approved by the FDA for moderate-to-severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback